Performance measurement evaluations provide Canadians with information on the effectiveness of the risk management actions in place for the substances that are found to be toxic under the Canadian Environmental Protection Act, 1999 (CEPA 1999). The risk management, human health, and environmental objectives are systematically evaluated using robust data and expert analysis under this plan.
Performance Measurement Evaluation report has been published for Bis (2-ethylhexyl) phthalate having a CAS Registry Number 117-81-7.
DEHP was first assessed by the Government of Canada in 1994, where it was concluded that DEHP may enter the environment in a quantity or concentration or under conditions that may constitute a danger in Canada to human health. Risk management tools (Cosmetic Ingredient Hotlist , the Phthalates Regulations , reporting of DEHP content under the Medical Devices Regulations , and provisions under the Food and Drugs Act ) were established to help reduce exposure of DEHP to the general population of Canada in these products.
Overall, risk management tools are intended to meet their goals. Biomonitoring data was collected from three cycles (2007 to 2017) of the Canadian Health Measures Survey (CHMS) which indicates that Canadians’ exposure to DEHP has progressively decreased since risk management tools were adopted.
The performance measurement evaluation recommends ongoing measurement of DEHP in the CHMS and monitoring of the Phthalates Regulations. Ongoing reporting of DEHP concentrations in medical devices is also recommended.
Concluded details on the Performance Management Evaluation for DEHP can be accessed at Performance Measurement Evaluation for Risk Management of Bis(2-ethylhexyl) phthalate (DEHP), Health Component.
Latest update: 2021-06-30